基本信息
浏览量:0
职业迁徙
个人简介
Research Overview
This group leads key research in emerging infection diseases, travel medicine and antimicrobial stewardship. This includes research preparedness platforms for emerging infectious diseases, biobanks and data linkage for infectious disease registries. Dr Thevarajan is the lead investigator in a prospective observational project in APPRISE, Sentinel Travellers and Research Preparedness Platform for Emerging Infectious Disease (SETREP-ID), that rapidly detects and characterise emerging infectious diseases by enabling in-depth data collection, biological sampling and bio-banking. The Platform was activated in the Pandemic with a prospective cohort of hospitalised COVID-19 cases. This collaborative research preparedness platform is funded by NHMRC and APPRISE (Australian Partnership for Preparedness Research on Infectious Disease Emergencies). It was one of Australia’s first research platforms to be mobilised for the COVID-19 pandemic and has led to one of the earliest publications in Nature Medicine in the immune responses to a recovering COVID-19 infected individual (Nature Med Thevarajan et al. 2020). The SETREP-ID protocol is aligned with the International platform, International Severe Acute Respiratory and Emerging Infection Consortium, has facilitated national groups including the Australian paediatric network in collaborative large-scale research and, has a well-characterised COVID-19 biobank that is supporting multiple COVID-19 investigator initiated studies. In addition, the group is involved with qualitative studies on health care workers approach to diseases of high-consequence (Viral Haemorrhagic fevers) and the impact of COVID-19 on healthcare workers.
This group leads key research in emerging infection diseases, travel medicine and antimicrobial stewardship. This includes research preparedness platforms for emerging infectious diseases, biobanks and data linkage for infectious disease registries. Dr Thevarajan is the lead investigator in a prospective observational project in APPRISE, Sentinel Travellers and Research Preparedness Platform for Emerging Infectious Disease (SETREP-ID), that rapidly detects and characterise emerging infectious diseases by enabling in-depth data collection, biological sampling and bio-banking. The Platform was activated in the Pandemic with a prospective cohort of hospitalised COVID-19 cases. This collaborative research preparedness platform is funded by NHMRC and APPRISE (Australian Partnership for Preparedness Research on Infectious Disease Emergencies). It was one of Australia’s first research platforms to be mobilised for the COVID-19 pandemic and has led to one of the earliest publications in Nature Medicine in the immune responses to a recovering COVID-19 infected individual (Nature Med Thevarajan et al. 2020). The SETREP-ID protocol is aligned with the International platform, International Severe Acute Respiratory and Emerging Infection Consortium, has facilitated national groups including the Australian paediatric network in collaborative large-scale research and, has a well-characterised COVID-19 biobank that is supporting multiple COVID-19 investigator initiated studies. In addition, the group is involved with qualitative studies on health care workers approach to diseases of high-consequence (Viral Haemorrhagic fevers) and the impact of COVID-19 on healthcare workers.
研究兴趣
论文共 28 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
JCI insightno. 6 (2023)
Communicable diseases intelligence (2018) (2023)
引用3浏览0WOSNATURE引用
3
0
JCI insightno. 7 (2023)
引用1浏览0引用
1
0
JOURNAL OF IMMUNOLOGYno. 1 (2022)
Adam Jenney,Doris Chibo,Mitch Batty,Julian Druce,Robert Melvin,Andrew Stewardson,Amanda Dennison, Sally Symes,Paul Kinsella,Thomas Tran,Charlene Mackenzie, Douglas Johnson,
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn